ZA975565B - Antiviral combinations - Google Patents

Antiviral combinations

Info

Publication number
ZA975565B
ZA975565B ZA975565A ZA975565A ZA975565B ZA 975565 B ZA975565 B ZA 975565B ZA 975565 A ZA975565 A ZA 975565A ZA 975565 A ZA975565 A ZA 975565A ZA 975565 B ZA975565 B ZA 975565B
Authority
ZA
South Africa
Prior art keywords
antiviral combinations
antiviral
combinations
Prior art date
Application number
ZA975565A
Other languages
English (en)
Inventor
Martha Heider St Clair
David Walter Barry
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9614024.9A external-priority patent/GB9614024D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA975565B publication Critical patent/ZA975565B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA975565A 1996-06-25 1997-06-23 Antiviral combinations ZA975565B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2217896P 1996-06-25 1996-06-25
GBGB9614024.9A GB9614024D0 (en) 1996-07-04 1996-07-04 Antiviral therapeutic combinations
PCT/EP1997/003246 WO1997049410A1 (en) 1996-06-25 1997-06-23 Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv

Publications (1)

Publication Number Publication Date
ZA975565B true ZA975565B (en) 1998-12-23

Family

ID=26309631

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA975565A ZA975565B (en) 1996-06-25 1997-06-23 Antiviral combinations

Country Status (26)

Country Link
US (1) US6486136B1 (ru)
EP (1) EP0910386B1 (ru)
KR (1) KR20000022225A (ru)
CN (1) CN1306430A (ru)
AP (1) AP9801418A0 (ru)
AT (1) ATE230267T1 (ru)
AU (1) AU723877C (ru)
BR (1) BR9709951A (ru)
CA (1) CA2262765A1 (ru)
CO (1) CO4910137A1 (ru)
CZ (1) CZ429398A3 (ru)
DE (1) DE69718168T2 (ru)
EA (1) EA001457B1 (ru)
ES (1) ES2189964T3 (ru)
HU (1) HUP9903098A3 (ru)
ID (1) ID18739A (ru)
IL (1) IL127350A0 (ru)
IS (1) IS4913A (ru)
NO (1) NO986035L (ru)
NZ (1) NZ333098A (ru)
PE (1) PE87398A1 (ru)
PL (1) PL330791A1 (ru)
TR (1) TR199802703T2 (ru)
WO (1) WO1997049410A1 (ru)
YU (1) YU58498A (ru)
ZA (1) ZA975565B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115461A (en) 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9709945D0 (en) 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
NZ500868A (en) * 1997-05-17 2001-08-31 Glaxo Group Ltd Antiviral combinations comprising 1592U89 and HIV protease inhibitors
GB9802472D0 (en) * 1998-02-06 1998-04-01 Glaxo Group Ltd Pharmaceutical compositions
AU4716299A (en) * 1998-06-24 2000-01-10 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
GB9104740D0 (en) * 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
GB9307013D0 (en) * 1993-04-02 1993-05-26 Wellcome Found Therapeutic combinations
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
UA49803C2 (ru) 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Способ лечения ретровирусных инфекций
US5646180A (en) * 1995-12-05 1997-07-08 Vertex Pharmaceuticals Incorporated Treatment of the CNS effects of HIV

Also Published As

Publication number Publication date
IS4913A (is) 1998-11-30
YU58498A (en) 1999-11-22
AU723877C (en) 2001-08-23
BR9709951A (pt) 1999-08-10
ID18739A (id) 1998-05-07
EP0910386A1 (en) 1999-04-28
NZ333098A (en) 2000-08-25
AP9801418A0 (en) 1998-12-31
CN1306430A (zh) 2001-08-01
EA199801046A1 (ru) 1999-08-26
WO1997049410A1 (en) 1997-12-31
ATE230267T1 (de) 2003-01-15
HUP9903098A2 (hu) 1999-12-28
PE87398A1 (es) 1999-01-15
HU9903098D0 (en) 1999-10-28
AU3262697A (en) 1998-01-14
TR199802703T2 (xx) 1999-03-22
ES2189964T3 (es) 2003-07-16
US6486136B1 (en) 2002-11-26
AU723877B2 (en) 2000-09-07
CA2262765A1 (en) 1997-12-31
CO4910137A1 (es) 2000-04-24
NO986035L (no) 1999-02-23
KR20000022225A (ko) 2000-04-25
DE69718168D1 (de) 2003-02-06
IL127350A0 (en) 1999-10-28
HUP9903098A3 (en) 2000-01-28
PL330791A1 (en) 1999-06-07
EA001457B1 (ru) 2001-04-23
CZ429398A3 (cs) 1999-05-12
EP0910386B1 (en) 2003-01-02
NO986035D0 (no) 1998-12-22
DE69718168T2 (de) 2003-10-23

Similar Documents

Publication Publication Date Title
DE59704951D1 (en) Plättchenförmiges titandioxidpigment
DE59711450D1 (en) Arylalkanoylpyridazine
DE59700372D1 (en) Blockcopolymere
HU9700567D0 (en) Herbicid combinations
DE59707730D1 (en) Peripheralpumpe
DE59703905D1 (en) Linearmotorgetriebene transportanlage
DE59704086D1 (en) Twin-dualmode-filter
GB9820420D0 (en) Antiviral combinations
ZA975565B (en) Antiviral combinations
DE59703023D1 (en) Cyclopeptidderivate
DE59702027D1 (en) Bragg-modulator
DE59711583D1 (en) Heterocyclyluracile
DE59709914D1 (en) Substituierte aromatische phosphonsäurederivate
DE59705556D1 (en) Peripheralpumpe
GB9820417D0 (en) Antiviral combinations
HUP9901287A3 (en) Coin-checking arrangement
AU131132S (en) Handleset
GB9821000D0 (en) Antiviral combinations
AU131198S (en) Handleset
ZA975564B (en) Antiviral combinations
DE59610178D1 (en) Rotationspumpe
GB9820416D0 (en) Antiviral combinations
GB9719883D0 (en) Antiviral combinations
GB9719866D0 (en) Antiviral Combinations
AU131131S (en) Handleset